Trial Details

Authorised
Basic Information
Clinical ID c5113
Identifier EUCTR2011-006084-22-GB
Trial Title Utilising drug levels and anti-drug antibodies to predict response to treatment in patients with Inflammatory Bowel Disease - Trough levels of anti-TNF agents in inflammatory bowel disease
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Inflammatory bowel disease MedDRA version: 14.1.Level: LLT.Classification code 10045365.Term: Ulcerative colitis.System Organ Class: 10017947 - Gastrointestinal disorders. MedDRA version: 14.1.Level:
Interventions Trade Name: RemicadeProduct Name: InfliximabPharmaceutical Form: InfusionINN or Proposed INN: InfliximabCAS Number: 170277-31-3 Current Sponsor code: CentocorConcentration unit: mg milligram(s)Concentration type: up toC
Participant Information
Sponsor Royal Liverpool University Hospital
City NULL
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement NULL
Study Design
Study Type Interventional clinical trial of medicinal product
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL